Comparison Overview

Tandem Diabetes Care

VS

Baxter International Inc.

Tandem Diabetes Care

12400 High Bluff Drive , None, San Diego, California, US, 92130
Last Update: 2025-12-19

Tandem Diabetes Care, a global insulin delivery and diabetes technology company, manufactures and sells advanced automated insulin delivery systems that reduce the burden of diabetes management, while creating new possibilities for patients, their loved ones, and healthcare providers. The Company’s pump portfolio features the Tandem Mobi system and t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Tandem is the #1 recommended insulin pump brand by people living with diabetes, four years and counting. (dQ&A US Diabetes Connections Patient Panel Report; Net Promoter Score; Q1 2019-Q3 2023: P.49, Q3 2023 (Jan. 2019-Sept. 2023). Tandem Diabetes Care is based in San Diego, California. For more information, visit tandemdiabetes.com. SAFETY INFORMATION Please note that this account is not intended to be used for product support or medical advice. If you are having a medical emergency, please dial 911. If you are having an issue with one of our products and need immediate assistance, please call our 24-hour customer support team at 877-801-6901 and press 1 twice. RX ONLY. Indicated for patients with type 1 diabetes, 6 years and older. WARNING: Control-IQ technology should not be used by people under age 6, or who use less than 10 units of insulin/day, or who weigh less than 55 lbs. Safety info: tandemdiabetes.com/safetyinfo.

NAICS: 3391
NAICS Definition: Medical Equipment and Supplies Manufacturing
Employees: 2,186
Subsidiaries: 0
12-month incidents
0
Known data breaches
1
Attack type number
1

Baxter International Inc.

1 Baxter Pkwy, Deerfield, Illinois, US, 60015
Last Update: 2025-12-17
Between 700 and 749

For nearly a century, we have delivered on our commitment to saving and sustaining the lives of patients, working alongside clinicians and providers around the world. We believe every person — regardless of who they are or where they are from — deserves a chance to live a healthy life, free from illness and full of possibility. At the intersection of progress and purpose is where we are redefining what it means to be a global medtech leader. It is where we are relentlessly pursuing healthcare transformation, fueled by our compassion for patients and providers and the challenges they face. It is where bold ideas meet the promise for meaningful change in the world around us. We are there, at every step of the journey, to help clinicians deliver the best care possible.

NAICS: 3391
NAICS Definition: Medical Equipment and Supplies Manufacturing
Employees: 36,242
Subsidiaries: 28
12-month incidents
0
Known data breaches
2
Attack type number
1

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/tandemdiabetes.jpeg
Tandem Diabetes Care
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/baxter-healthcare.jpeg
Baxter International Inc.
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
Tandem Diabetes Care
100%
Compliance Rate
0/4 Standards Verified
Baxter International Inc.
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Medical Equipment Manufacturing Industry Average (This Year)

No incidents recorded for Tandem Diabetes Care in 2025.

Incidents vs Medical Equipment Manufacturing Industry Average (This Year)

No incidents recorded for Baxter International Inc. in 2025.

Incident History — Tandem Diabetes Care (X = Date, Y = Severity)

Tandem Diabetes Care cyber incidents detection timeline including parent company and subsidiaries

Incident History — Baxter International Inc. (X = Date, Y = Severity)

Baxter International Inc. cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/tandemdiabetes.jpeg
Tandem Diabetes Care
Incidents

Date Detected: 1/2020
Type:Breach
Attack Vector: Phishing
Blog: Blog
https://images.rankiteo.com/companyimages/baxter-healthcare.jpeg
Baxter International Inc.
Incidents

Date Detected: 6/2024
Type:Breach
Blog: Blog

Date Detected: 5/2024
Type:Breach
Blog: Blog

FAQ

Tandem Diabetes Care company demonstrates a stronger AI Cybersecurity Score compared to Baxter International Inc. company, reflecting its advanced cybersecurity posture governance and monitoring frameworks.

Baxter International Inc. company has faced a higher number of disclosed cyber incidents historically compared to Tandem Diabetes Care company.

In the current year, Baxter International Inc. company and Tandem Diabetes Care company have not reported any cyber incidents.

Neither Baxter International Inc. company nor Tandem Diabetes Care company has reported experiencing a ransomware attack publicly.

Both Baxter International Inc. company and Tandem Diabetes Care company have disclosed experiencing at least one data breach.

Neither Baxter International Inc. company nor Tandem Diabetes Care company has reported experiencing targeted cyberattacks publicly.

Neither Tandem Diabetes Care company nor Baxter International Inc. company has reported experiencing or disclosing vulnerabilities publicly.

Neither Tandem Diabetes Care nor Baxter International Inc. holds any compliance certifications.

Neither company holds any compliance certifications.

Baxter International Inc. company has more subsidiaries worldwide compared to Tandem Diabetes Care company.

Baxter International Inc. company employs more people globally than Tandem Diabetes Care company, reflecting its scale as a Medical Equipment Manufacturing.

Neither Tandem Diabetes Care nor Baxter International Inc. holds SOC 2 Type 1 certification.

Neither Tandem Diabetes Care nor Baxter International Inc. holds SOC 2 Type 2 certification.

Neither Tandem Diabetes Care nor Baxter International Inc. holds ISO 27001 certification.

Neither Tandem Diabetes Care nor Baxter International Inc. holds PCI DSS certification.

Neither Tandem Diabetes Care nor Baxter International Inc. holds HIPAA certification.

Neither Tandem Diabetes Care nor Baxter International Inc. holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

Zerobyte is a backup automation tool Zerobyte versions prior to 0.18.5 and 0.19.0 contain an authentication bypass vulnerability where authentication middleware is not properly applied to API endpoints. This results in certain API endpoints being accessible without valid session credentials. This is dangerous for those who have exposed Zerobyte to be used outside of their internal network. A fix has been applied in both version 0.19.0 and 0.18.5. If immediate upgrade is not possible, restrict network access to the Zerobyte instance to trusted networks only using firewall rules or network segmentation. This is only a temporary mitigation; upgrading is strongly recommended.

Risk Information
cvss3
Base: 9.1
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:N
Description

Open Source Point of Sale (opensourcepos) is a web based point of sale application written in PHP using CodeIgniter framework. Starting in version 3.4.0 and prior to version 3.4.2, a Cross-Site Request Forgery (CSRF) vulnerability exists in the application's filter configuration. The CSRF protection mechanism was **explicitly disabled**, allowing the application to process state-changing requests (POST) without verifying a valid CSRF token. An unauthenticated remote attacker can exploit this by hosting a malicious web page. If a logged-in administrator visits this page, their browser is forced to send unauthorized requests to the application. A successful exploit allows the attacker to silently create a new Administrator account with full privileges, leading to a complete takeover of the system and loss of confidentiality, integrity, and availability. The vulnerability has been patched in version 3.4.2. The fix re-enables the CSRF filter in `app/Config/Filters.php` and resolves associated AJAX race conditions by adjusting token regeneration settings. As a workaround, administrators can manually re-enable the CSRF filter in `app/Config/Filters.php` by uncommenting the protection line. However, this is not recommended without applying the full patch, as it may cause functionality breakage in the Sales module due to token synchronization issues.

Risk Information
cvss3
Base: 8.8
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H
Description

Zed, a code editor, has an aribtrary code execution vulnerability in versions prior to 0.218.2-pre. The Zed IDE loads Model Context Protocol (MCP) configurations from the `settings.json` file located within a project’s `.zed` subdirectory. A malicious MCP configuration can contain arbitrary shell commands that run on the host system with the privileges of the user running the IDE. This can be triggered automatically without any user interaction besides opening the project in the IDE. Version 0.218.2-pre fixes the issue by implementing worktree trust mechanism. As a workaround, users should carefully review the contents of project settings files (`./zed/settings.json`) before opening new projects in Zed.

Risk Information
cvss3
Base: 7.7
Severity: HIGH
CVSS:3.1/AV:L/AC:H/PR:N/UI:R/S:C/C:H/I:H/A:H
Description

Zed, a code editor, has an aribtrary code execution vulnerability in versions prior to 0.218.2-pre. The Zed IDE loads Language Server Protocol (LSP) configurations from the `settings.json` file located within a project’s `.zed` subdirectory. A malicious LSP configuration can contain arbitrary shell commands that run on the host system with the privileges of the user running the IDE. This can be triggered when a user opens project file for which there is an LSP entry. A concerted effort by an attacker to seed a project settings file (`./zed/settings.json`) with malicious language server configurations could result in arbitrary code execution with the user's privileges if the user opens the project in Zed without reviewing the contents. Version 0.218.2-pre fixes the issue by implementing worktree trust mechanism. As a workaround, users should carefully review the contents of project settings files (`./zed/settings.json`) before opening new projects in Zed.

Risk Information
cvss3
Base: 7.7
Severity: HIGH
CVSS:3.1/AV:L/AC:H/PR:N/UI:R/S:C/C:H/I:H/A:H
Description

Storybook is a frontend workshop for building user interface components and pages in isolation. A vulnerability present starting in versions 7.0.0 and prior to versions 7.6.21, 8.6.15, 9.1.17, and 10.1.10 relates to Storybook’s handling of environment variables defined in a `.env` file, which could, in specific circumstances, lead to those variables being unexpectedly bundled into the artifacts created by the `storybook build` command. When a built Storybook is published to the web, the bundle’s source is viewable, thus potentially exposing those variables to anyone with access. For a project to potentially be vulnerable to this issue, it must build the Storybook (i.e. run `storybook build` directly or indirectly) in a directory that contains a `.env` file (including variants like `.env.local`) and publish the built Storybook to the web. Storybooks built without a `.env` file at build time are not affected, including common CI-based builds where secrets are provided via platform environment variables rather than `.env` files. Storybook runtime environments (i.e. `storybook dev`) are not affected. Deployed applications that share a repo with your Storybook are not affected. Users should upgrade their Storybook—on both their local machines and CI environment—to version .6.21, 8.6.15, 9.1.17, or 10.1.10 as soon as possible. Maintainers additionally recommend that users audit for any sensitive secrets provided via `.env` files and rotate those keys. Some projects may have been relying on the undocumented behavior at the heart of this issue and will need to change how they reference environment variables after this update. If a project can no longer read necessary environmental variable values, either prefix the variables with `STORYBOOK_` or use the `env` property in Storybook’s configuration to manually specify values. In either case, do not include sensitive secrets as they will be included in the built bundle.

Risk Information
cvss3
Base: 7.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L